Resources

• 

  Clinical trials

  Clinical trials are needed to see if a medicine is safe and if it works. This factsheet provides a brief introduction to the types of

  From: Factsheets

  Information level Level 2
• 

  Clinical trials

  This booklet answers the questions that people with HIV often ask about clinical trials

  From: Booklets

  Information level Level 2

Features

• 

  Making sense of randomised trials

  Want to know more about cutting edge treatment news but feeling blinded by science? Caroline Sabin, Professor of Medical Statistics and Epidemiology at University College London, describes

  From: HIV treatment update

  Information level Level 3
• 

  HATIP #38, 22nd December 2004

  From: HIV & AIDS treatment in practice

  Information level Level 4

Aidsmap news

• Imiquimod a good treatment for pre-cancerous anal lesions in men with HIV

  02 September 2010 | Michael Carter

• What happens to people who become HIV positive in prevention trials?

  01 June 2010 | Gus Cairns

• Six existing drug classes now being tested as microbicides

  23 May 2010 | Gus Cairns

• Protease inhibitor monotherapy in clinical practice: valid option for undetectable patients

  27 April 2010 | Gus Cairns

• Rilpivirine proves non-inferior to efavirenz in phase 3 studies

  20 April 2010 | Keith Alcorn

• d4T dose reduction does not result in poorer treatment outcomes in South African patients

  04 September 2009 | Keith Alcorn

• Early treatment and interruption makes no difference to disease progression, study finds

  04 September 2009 | Gus Cairns

• Trizivir approved in Europe

  05 March 2001 | Keith Alcorn

• What to do with nelfinavir?

  05 March 2001 | Keith Alcorn

• Triple PI salvage therapy

  05 March 2001 | Keith Alcorn

More news

News selected from other sources

• Good Participatory Practice (GPP) Guidelines

  29 July 2010